Devonian Health Group Inc. announced progress on its planned initial public offering (IPO) and listing on the NYSE American, but the exact timing for trading commencement and offering closure remains undetermined. The company is working with ThinkEquity and awaiting necessary regulatory approvals from NYSE American LLC and the TSX Venture Exchange. The IPO aims to list Devonian's common shares and warrants under symbols DHGR and DHGR WS. Market conditions and regulatory approvals will influence the final outcome, and there is no guarantee the offering will be completed as planned. Devonian remains listed on the TSXV and specializes in developing drugs for autoimmune fibroinflammatory diseases.
Devonian Health Group's planned NYSE American listing is the subject, with Pluang's health sector market data as context. As of Oct 16, 2026 19:42 WIB, out of 150 priced health-sector US stocks tradable on Pluang, 96 rose and 43 fell. Notable movers include Immunovant Inc. (IMVT) at USD 27.98 with a 1-day change of +1.69% and a typical hold time of 7 days, Roivant Sciences Ltd. (ROIV) at USD 34.61 with a +1.67% change and a 4-day hold time, and Recursion Pharmaceuticals Inc. (RXRX) at USD 4.09 with a -1.56% change, where Pluang order activity was 41% Sell and 59% Buy. The most notable figure is the 96 stocks that rose today.
Opus Genetics announced FDA approval of phentolamine ophthalmic solution 0.75% for treating presbyopia, an age-related condition affecting near vision in adults. This approval, based on successful Phase 3 trials, provides a non-invasive option that i...
K2 Vision has completed over 5,000 procedures using the Light Adjustable Lens (LAL), making it the highest-volume practice worldwide for this technology. The LAL is unique because it can be adjusted after implantation to fine-tune vision based on the...
BlackRock, Inc. disclosed that its voting rights in pharmaceutical company Fagron NV fell below the 3% reporting threshold due to the transfer of voting securities, despite acquiring financial instruments equivalent to voting rights. As of October 12...
BlackRock, Inc. disclosed that its shareholding in Fagron NV dropped below the 3% threshold to 2.96% after selling some voting securities, despite acquiring equivalent financial instruments. As of October 12, 2026, BlackRock holds 2,015,779 voting ri...
Meridian International Center announced its inaugural New Architects of American Influence cohort, recognizing 25 leaders from business, technology, culture, sports, and government who are shaping U.S. global influence. The 2026 cohort includes leade...
